
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>The business case for pharmaceutical management : a case study of Henry Ford Health System</dc:title>
  <dc:title>Field report (Commonwealth Fund)</dc:title>
  <dc:subject>Henry Ford Health System.</dc:subject>
  <dc:subject>Drug Therapy -- economics</dc:subject>
  <dc:subject>Venous Thrombosis -- drug therapy</dc:subject>
  <dc:subject>Hypercholesterolemia -- drug therapy</dc:subject>
  <dc:subject>Cost-Benefit Analysis</dc:subject>
  <dc:subject>Organizational Case Studies</dc:subject>
  <dc:description>This case study explores two innovations in pharmacy management at the Henry Ford Health System.</dc:description>
  <dc:publisher>[New York] : Commonwealth Fund, [2003]</dc:publisher>
  <dc:contributor>Smits, Helen L.</dc:contributor>
  <dc:contributor>Commonwealth Fund.</dc:contributor>
  <dc:format>Text</dc:format>
  <dc:format>Illustrations</dc:format>
  <dc:identifier>nlm:nlmuid-101184316-pdf</dc:identifier>
  <dc:identifier>101184316</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101184316</dc:identifier>
  <dc:language>English</dc:language>
  <dc:coverage>Michigan</dc:coverage>
  <dc:rights>Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. https://creativecommons.org/licences/by/4.0</dc:rights>
</oai_dc:dc>
